Reddy Malireddy S – ‘SC 13D’ on 1/30/15 re: Greenhouse Solutions, Inc.

On:  Friday, 1/30/15, at 4:41pm ET   ·   Accession #:  1072588-15-15   ·   File #:  5-86393

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

General Statement of Beneficial Ownership   —   Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      General Statement of Beneficial Ownership              5     12K 

Document Table of Contents

SC 13D
1st Page of 5
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

 Under the Securities Exchange Act of 1934

 Greenhouse Solutions Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

 39530T103

(CUSIP Number)

Dr. Malireddy S. Reddy
c/o ADFAC/IMAC
1250 S. Parker Road, Suite 203
Denver, CO 80231
303-944-5215

(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)

January 21, 2015

 (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of ss.  240.13d-1(e),  240.13d-1(f) or 240.13d-1(g),  check the
following box: ____                                                             

SC 13D
2nd Page of 5
TOC
1st
Previous
Next
↓Bottom
Just 2nd
SCHEDULE 13D

1.       NAME OF REPORTING PERSON                                               

Dr. Malireddy S. Reddy                                        

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                       
a.       ___                                                  
b.       ___                                                  

3.       SEC USE ONLY                                                           

4.       SOURCE OF FUNDS                                                        

PF                                                            

5.       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO   
ITEMS 2(d) or 2(e)  ______                                    

6.       CITIZENSHIP OR PLACE OF ORGANIZATION                                   

USA                                                           

7.       NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH      

SOLE VOTING POWER                                   

7,000,000                                   

8.            SHARED VOTING POWER                                               

0                                           

9.            SOLE DISPOSITIVE POWER                                            

7,000,000                                   

10.           SHARED DISPOSITIVE POWER                                          

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON           

7,000,000                                           

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN         
SHARES _____                                                  

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                     

7.8%                                                

14.      TYPE OF REPORTING PERSON                                               

IN                                                            

ITEM 1. SECURITY AND ISSUER                                                     

This statement on Schedule 13D  ("Schedule  13D") is being filed with respect to
the  common  stock,  $0.0001  par value  (the  "common  Stock"),  of  Greenhouse
Solutions Inc., a Nevada  corporation (the "Company").  The Company's  principal
executive office is located at 8400 E. Crescent  Parkway,  Suite 600,  Greenwood
Village, Colorado 80111.                                                        

2 

SC 13D
3rd Page of 5
TOC
1st
Previous
Next
↓Bottom
Just 3rd
ITEM 2. IDENTITY AND BACKGROUND                                                 

(a) This statement is filed by Dr.  Malireddy S. Reddy (the "Reporting  Person")
with respect to shares directly owned by him.                                   

Any disclosures  herein with respect to persons other than the Reporting  Person
is made on information and belief after making inquiry to the appropriate party.

(b) The business address of Dr.  Malireddy S. Reddy is c/o ADFAC/IMPAC,  1250 S.
Parker Road, Suite 203, Denver, CO 80231.                                       

(c) The Reporting Person has not, during the last five years,  been convicted in
a criminal proceeding (excluding traffic violations or similar misdemeanors).   

(d) The Reporting Person has not, during the last five years,  been a party to a
civil proceeding of a judicial or administrative body of competent  jurisdiction
and as a result of such  proceeding  was or is subject to a judgment,  decree or
final  order  enjoining  future  violations  of,  or  prohibiting  or  mandating
activities subject to, federal or state securities laws or finding any violation
with respect to such laws.                                                      

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION                       

On January 21, 2015,  the  Reporting  Person  acquired  7,000,000  shares of the
Company's  voting  Common  Stock  issued for a License  for  certain IP owned by
Reporting Person.                                                               

ITEM 4. PURPOSE OF TRANSACTION                                                  

The shares of Common Stock owned by the Reporting  Person were acquired for, and
are being held for,  investment  purposes.  As discussed  above, the shares were
acquired pursuant to a License granted by Reporting Person.                     

The Reporting  Person may in the future directly  acquire shares of Common Stock
in open  market or private  transactions,  block  purchases  or  otherwise.  The
Reporting  Person  may  continue  to  hold  or  dispose  of all or  some  of the
securities  reported  herein  from time to time,  in each case in open market or
private  transactions,  block  sales  or  purchases  or  otherwise,  subject  to
compliance with  applicable  law. Other than as set forth herein,  the Reporting
Person has no plans or proposals which relate to, or could result in, any of the
matters referred to in paragraphs (b) through (j),  inclusive,  of Item 4 of the
Schedule  13D.  The  Reporting  Person  may,  at any time and from time to time,
review or reconsider his position and formulate  plans or proposals with respect
thereto, but has no present intention of doing so.                              

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER                                    

(a) As of the close of business on January 21, 2015,  the  Reporting  Person was
the beneficial  owner,  within the meaning of Rule 13d-3 under the Exchange Act,
of  7,000,000  shares of common  Stock.  As of January 21,  2015,  these  shares
represented  7.8% of the voting power of the  88,760,000  total voting shares of
the Company's capital stock outstanding as reported.                            

(b) The sole or shared  power to vote or  dispose  of, or to direct  the vote or
disposition of the Common Stock with respect to each  Reporting  Person noted in
paragraph  (a) of  this  Item 5 is as set  forth  on the  cover  sheets  of this
Schedule 13D.                                                                   

(c) There have been no transactions  involving the shares of Common Stock of the
Company  engaged in during the 60 day period prior to and including  January 21,
2015, up to the present.                                                        

3 

SC 13D
4th Page of 5
TOC
1st
Previous
Next
↓Bottom
Just 4th
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER                                                        

There are no contracts, arrangements,  understandings or relationships (legal or
otherwise)  among the  Reporting  person named in Item 2 of this  statement  and
between such  Reporting  Person and any person with respect to any securities of
the  Company,  including  but not  limited to  transfer  or voting of any of the
securities,  finder's fees, joint ventures, loan or arrangements, puts or calls,
guarantees of profits, division of profits or loss, or the giving or withholding
of proxies.                                                                     

A new business  direction is being pursued with new  management  and with equity
participation by new principals.  The  CEO/Director,  Rik Dietsch,  has acquired
4,000,000   shares  of  Common  Stock  (4.51%)  for  a  Sub-License  of  certain
proprietary  formulations  related  to CBD  Oil and as may be  legally  allowed,
marijuana products. The President/Director,  Redgie Green, has purchased 200,000
shares of Common Stock (0.23%), and Director, John G. Michak, III, has purchased
29,000,000  shares of common Stock  (32.7%) from George Dory.  Mr. Dory returned
11,000,000  shares  of stock to  treasury.  There is an  understanding  that the
license and  Sub-License  provided to the Company by Dr.  Reddy and Mr.  Dietsch
respectively  are  conditioned  on  performance  thereunder.  Dr. Reddy received
7,000,000  shares as consideration  for a License of probiotic  formulas for CBD
Oil and marijuana products if legal.                                            

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS                                        

Exhibit 10.1 License Agreement Between Dr. M.S. Reddy and Greenhouse  Solutions,
Inc.                                                                            

4 

SC 13D
Last Page of 5
TOC
1st
Previous
Next
↓Bottom
Just 5th
SIGNATURES

After  reasonable  inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete, correct.    

            /s/ Malireddy S. Reddy
                                   ---------------------------------------------
            Dr. Malireddy S. Reddy

5 

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘SC 13D’ Filing		Date		First		Last			Other Filings
Filed on:		1/30/15							3
		1/21/15		1		3			3,  8-K
									List all Filings